Determinants of drug entry into the developing brain [version 1; peer review: 2 approved]
Background: A major concern for clinicians in prescribing medications to pregnant women and neonates is the possibility that drugs might have damaging effects, particularly on long-term brain development. Current understanding of drug permeability at placental and blood-brain barriers during develop...
Main Authors: | Liam Koehn, Mark Habgood, Yifan Huang, Katarzyna Dziegielewska, Norman Saunders |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-08-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-1372/v1 |
Similar Items
-
Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies [version 1; peer review: 2 approved]
by: Mark Habgood, et al.
Published: (2022-12-01) -
Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies [version 2; peer review: 2 approved]
by: Mark Habgood, et al.
Published: (2023-02-01) -
Entry of antiepileptic drugs (valproate and lamotrigine) into the developing rat brain [version 1; peer review: 2 approved]
by: Samuel J. Toll, et al.
Published: (2021-05-01) -
Effects of paracetamol (acetaminophen) on gene expression and permeability properties of the rat placenta and fetal brain [version 2; peer review: 2 approved]
by: Liam M. Koehn, et al.
Published: (2020-08-01) -
Age dependent contribution of entry via the CSF to the overall brain entry of small and large hydrophilic markers
by: Fiona Qiu, et al.
Published: (2022-11-01)